You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) SODIUM TARTRATE DIHYDRATE


✉ Email this page to a colleague

« Back to Dashboard


Market Dynamics and Financial Trajectory for Sodium Tartrate Dihydrate

Last updated: February 20, 2026

What is the Global Market Size and Growth Rate?

The global market for sodium tartrate dihydrate is estimated at approximately $50 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4% from 2023 to 2030. The growth stems from rising demand in the pharmaceutical industry, specifically in pharmaceutical formulations, effervescent tablets, and as a stabilizer in certain drugs.

Which Key Industry Drivers Influence Market Expansion?

The primary drivers include:

  • Growth in pharmaceutical manufacturing, especially in developing economies where excipient use is increasing.
  • Increased use of sodium tartrate dihydrate as a stabilizer and filler in effervescent drug formulations.
  • Expansion of markets for functional foods and beverages that utilize sugar derivates.
  • Regulatory approval of sodium tartrate dihydrate in pharmaceutical applications.

How Does the Supply Chain Look?

Major producers include:

  • China: Dominates with approximately 60% of global supply, driven by large-scale chemical manufacturing facilities.
  • India: Accounts for about 20%, with increasing exports to North America and Europe.
  • United States and Europe: Smaller production bases, mostly focused on specialty chemical manufacturing.

Raw material sourcing involves tartaric acid derived from grape processing and sodium compounds through chemical synthesis. The supply chain's stability impacts pricing and availability, with China’s manufacturing capacity being a critical factor.

What Are the Key Market Segments?

Segmented by application:

  • Pharmaceuticals: 55%
    • Effervescent tablets: 30%
    • Tablets and capsules: 15%
    • Parenteral formulations: 10%
  • Food and Beverages: 30%
    • Stabilizer and acidulant functions
  • Cosmetics & Personal Care: 10%
  • Industrial applications: 5%

Segment growth rates vary; pharmaceutical applications lead with a CAGR of 5%, driven by rising drug delivery innovations.

How Is Regulatory Environment Shaping the Market?

The U.S. Food and Drug Administration (FDA) considers sodium tartrate dihydrate as Generally Recognized As Safe (GRAS) for specific uses. The European Food Safety Authority (EFSA) also approves its use as a food additive. Ongoing regulatory evaluations focus on purity standards and contaminant limits, influencing manufacturing practices.

What Are Pricing Trends and Profitability Insights?

Prices have remained relatively stable between $10 and $20 per kilogram over the past five years. However, disruptions in Chinese supply, increased raw material costs, and stricter regulatory standards could induce price volatility.

Major suppliers report gross margins of approximately 20%. New entrants face high initial costs due to specialized production processes and regulatory compliance costs.

What Are Future Market Opportunities and Threats?

Opportunities include:

  • Expansion into emerging markets with growing pharmaceutical industries.
  • Development of derivative products for specialized applications.
  • Increasing demand for pharmaceutical excipients with high purity standards.

Threats involve:

  • Regulatory tightening, especially in export markets.
  • Raw material price swings.
  • Competitive pressures from alternative stabilizers and excipients.

How Robust Is the Financial Trajectory?

Financially, the industry shows stable growth with moderate profitability margins. Market players with diversified product portfolios and scalable manufacturing facilities are better positioned to capitalize on growth trends.

Research and development investments remain vital. Companies investing in process intensification and sustainable manufacturing practices may gain competitive advantages.

Key Takeaways

  • The sodium tartrate dihydrate market is valued at around $50 million in 2022, with a forecasted CAGR of 4% through 2030.
  • Pharmaceutical applications dominate, with effervescent formulations as primary drivers.
  • Major manufacturing occurs in China, with supply stability influencing prices.
  • Regulatory approvals support market growth, but evolving standards may impose compliance costs.
  • Price stability faces risks from raw material prices and supply disruptions.

FAQs

1. How does the regulatory environment impact the market? Regulatory approvals facilitate market access, but increased standards for purity and contaminants can raise manufacturing costs and delay product acceptance.

2. What are the main raw materials for sodium tartrate dihydrate? Tartaric acid derived from grape processing and sodium compounds synthesized from sodium hydroxide or carbonate.

3. Which regions offer the highest growth potential? Emerging markets in Asia-Pacific, particularly India and Southeast Asia, present significant expansion opportunities owing to increasing pharmaceutical and food processing industries.

4. Are there substitutes for sodium tartrate dihydrate in pharmaceutical formulations? Yes, compounds like calcium tartrate and other stabilizers can replace it, but may offer different efficacy or cost profiles.

5. What innovation areas could alter market dynamics in the next decade? Sustainable manufacturing processes, enhanced purity standards, and new derivative applications for targeted drug delivery.


References

  1. MarketsandMarkets. (2022). Pharmaceutical Excipients Market by Type, Source, Formulation, Application, and Region. [Online]
  2. U.S. Food and Drug Administration. (2023). GRAS Notices for Sodium Tartrate. [Online]
  3. European Food Safety Authority. (2022). Safety assessment of tartrate salts as food additives. [Online]
  4. Grand View Research. (2023). Global Pharmaceutical Excipients Market Size, Share & Trends. [Online]
  5. Liu, X., & Singh, P. (2021). Supply chain analysis of specialty chemicals in China. Chemical Market Review, 45(2), 50-66.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.